Navigation Links
Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
Date:2/26/2009

INDIANAPOLIS, Feb. 26 /PRNewswire-USNewswire/ -- America's pharmaceutical research and biotechnology companies are testing a record number of potential medicines to treat two of the country's top killers. According to the latest report by the Pharmaceutical Research and Manufacturers of America (PhRMA) on medicines in the research pipeline, over 300 new medicines are in development to treat heart disease and stroke.

"This report reflects the never-ending commitment of our scientists and companies to improve healthcare by fighting debilitating chronic diseases, which often have devastating impacts on patients, their families and the American economy," said PhRMA Senior Vice President Ken Johnson at today's press conference. "This report also illustrates why the U.S. leads the world in discovering and developing new medicines."

More research and development of new medicines takes place in the U.S. than in any other country. Indiana has a fair share of that, with more than 6 percent of the nation's pharmaceuticals workforce employed in the Hoosier state. At least 10 pharmaceutical companies are headquartered in Indiana, and at least 13 additional companies maintain a division, branch or manufacturing plant in Indiana. National Institutes of Health funding for Indiana's biosciences has grown nearly twice the national rate over the past six years. The biopharmaceutical research industry contributes significantly to the state's economy.

The 312 heart and stroke medicines now being developed, more than double the number (146) under development in 2005. Innovative potential heart and stroke medicines - five being developed here in Indiana - hold particular relevance to Hoosiers because cardiovascular disease and stroke are the leading causes of death in the state. Indiana also ranks high for many factors that increase the risk of developing cardiovascular disease, including higher-than-national rates for smoking, hi
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
2. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
3. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
4. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
5. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
6. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
7. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
8. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
9. MannKind Reports Successful Completion of Device Bioequivalence Trial
10. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
11. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Y, N.C., Nov. 20 Corners...ty pharmaceutical company focused on acquiring, de...primarily for the respiratory and related markets,...ter from the Food and Drug Administration ("FDA") ...enylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) a...
(Date:11/20/2009)...WOOD, Ill., Nov. 20 /PRNewswire-FirstCall/ -- L...sults for the fiscal fourth quarter and full year ..., The company will host a conference call for i.... Eastern Time. Investors may access the live call... and Canada), or 480-629-9835 (international calle...
(Date:11/20/2009)...RRISBURG, Pa., Nov. 20 ...e H1N1 flu shots to members of priority groups tha..., A total of 18 clinics are being held statewide ...m. to 8 p.m. Hours on Saturday, Nov. 21, will be 8...ll operate from 2 p.m. to 8 p.m. ,, Individual...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 1Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 2Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 3Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin 55052 4Gene Linked to Inherited Kidney Disease Found 55049 1Swine Flu Vaccine Seems Safe in Early Trials 55046 1Swine Flu Vaccine Seems Safe in Early Trials 55046 2Swine Flu Vaccine Seems Safe in Early Trials 55046 3
...rnational Conference on Antiviral,Research, SAN DI...RX,Pharmaceuticals, Inc. , a biopharmaceutical res...lizing proprietary product,candidates for the trea... today that it presented results demonstrating syn...a (bird flu) viruses when,the Company,s broad-spec...
...--May 4, 2007 - New data have,demonstrated that re...ts treated with COPAXONE(R) (glatiramer acetate in...toxantrone experienced a,90 percent reduction in m...activity compared to their baseline. These benefit...hout the 24-month study,period. These long-term da...
Other Medicine Technology:ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 2ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7
(Date:11/21/2009)...WASHINGTON, Nov. 21 Ton... proceed to Senator Reid,s version of the governme...ctionable items included in this bill; like the pu...the government funding for elective abortion, whic...dditionally the bill provides subsidies for privat...
(Date:11/21/2009)...NEW YORK, Nov. 21 Milvia Lopez, by... City, recently filed suit, in Supreme Court, New ...laint alleges that while Ms. Lopez underwent a rou.... VINCENT,S HOSPITAL , doctors used an HIV infecte... alleges that several hours after being discharged...
(Date:11/21/2009)... LONDON, November 21, 2009 /PRNewswire-FirstCall/...est Test Test Test Test Test Test Test Test Test,T...est Test Test Test Test,Test Test Test Test Test T...test More test More test More test More test More ...test More test More test More test More,test More ...
(Date:11/21/2009)... HAPPYneuron,s most popular and addic...one and iPod Touch. , Mou...euron,s most popular and addictive game, SplitWord...Split Words is designed to help banish that ,tip o...s iPhone brain game challenges the brain by enco...
(Date:11/21/2009)... Linwood Group ask whether there is a...easured? , London, UK (PR...t with up to one in three of the adult UK populati...eloping alcohol-related liver disease*, it is hard...o rehabilitation programmes and residential centre...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...placed an order for a stock of GlaxoSmithKline Plc... to protect its entire population.// According...ederal Office of Public Health had ordered 8 milli...gulatory file for the pre-pandemic vaccine by the ...
...number of chemotherapy patients has increased the ... requested to donate platelets.// According ...sh Cancer Society (ICS), in the last 5 years, ther... platelets every year. The Irish hospitals receive...
...al use for decades, a small, sweet-tasting compoun... cure for epilepsy.// 2-deoxy-glucose, or 2D...canning and cancer imaging studies in humans. But ... Reported in the journal Nature Neuroscience, the ...
...an earlier discovery that a gene called IRF6 is in...late, researchers at the University of Iowa Roy J....heir colleagues have identified the function of th...ells, a discovery that may have implications for w...
... home care for several thousands of elderly people...ors.// According to the Commission for Social ...re givers too rushed, giving insufficient time to ...". The government said that although there had bee...
...overnment-sponsored reports released on Tuesday re... spite of the risks due to contamination. These re... "Overall, for major health outcomes among adu...tructor in epidemiology at the Harvard School of P...
Other Medicine News:Health News:Chemotherapy increases the demand for blood components 2Health News:Commonplace Sugar Compound Silences Seizures 2Health News:Commonplace Sugar Compound Silences Seizures 3Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Standards of Home Care for Elderly Needs Change 2Health News:Eating Fish has more Benefits than Risks 2
Troutman-Barraquer Corneal Utility Forceps, Colibri Style - 0.5 mm
Catalano Corneal Scleral Forceps
Troutman-Barraquer Corneal Utility Forceps, Colibri Style
Colibri Forceps 0.12 mm
Medicine Products: